一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

返回ChemicalBook首頁>CAS數(shù)據(jù)庫列表>125404-04-8

125404-04-8

中文名稱 TCN 238
英文名稱 TCN 238
CAS 125404-04-8
分子式 C12H11N3
分子量 197.24
MOL 文件 125404-04-8.mol
更新日期 2024/12/03 15:40:37
125404-04-8 結(jié)構(gòu)式 125404-04-8 結(jié)構(gòu)式

基本信息

中文別名
化合物TCN 238
英文別名
TCN 238
TCN 238
TCN-238
4-Styryl-pyrimidin-2-ylamine
(E)-4-(2-Phenylethenyl)-2-pyriMidinaMine
2-PyriMidinaMine, 4-(2-phenylethenyl)-, (E)-
2-PyriMidinaMine, 4-(2-phenylethenyl)-, (E)- (9CI)
所屬類別
醫(yī)藥中間體:嘧啶類化合物

物理化學(xué)性質(zhì)

儲存條件-20°C儲存
溶解度DMF: 25 mg/ml; DMSO: 25 mg/ml; DMSO:PBS(pH7.2) (1:1): 0.5 mg/ml; Ethanol: 5 mg/ml
形態(tài)粉末
顏色White to off-white

應(yīng)用領(lǐng)域

用途1
TCN 238 allosteric modulator of the mGlu4 receptor. TCN 238 may be useful in the treatment of motor dysfunction and in the treatment of Parkinson鈥檚 disease. TCN 238 is orally bioavailable.

圖譜信息

TCN 238價格(試劑級)
報價日期產(chǎn)品編號產(chǎn)品名稱CAS號包裝價格
2026/06/05HY-14419TCN238125404-04-81 mg240元
2026/06/05HY-14419TCN 238
TCN238
125404-04-85mg600元
2026/06/05HY-14419TCN 238
TCN238
125404-04-810mM * 1mLin DMSO660元

常見問題列表

生物活性
TCN238 是一種口服有效的 mGlu4 受體的正變構(gòu)調(diào)節(jié)物,EC50 值為 1 μM。
靶點

mGlu4 Receptor

1 μM (EC 50 )

體外研究

In the rat mGlu4 PAM in vitro assay the EC 50 of TCN238 (Compound 11) is 1 μM which is comparable to the human assay. TCN238 is screened in rat and human mGlu5 assays, the IC 50 of 11 is >30 μM on human mGlu5and >10 μM on rat mGlu5. TCN238 is run in a receptor screening panel of 68 targets and no activity is observed at ≥50% at 10 μM for any of the receptors. In CaCo-2 cells, TCN238 is found to have good permeability with no apparent efflux issue.

體內(nèi)研究

TCN238 is highly CNS penetrant with a concentration of 33.8 μM in the brain. The plasma protein binding in rats is measured as 90% bound. The metabolic stability of TCN238 is assessed in rat and human microsomes and found to be 62% and 83% hepatic blood flow. The limited stability translated into a high in vivo clearance in rats of 75 mL/min/kg and TCN238 has a moderate volume of distribution (2.7 L/kg) with a short mean residence time (0.6 h) when dosed at 2 mg/kg via intravenous injection. TCN238 is orally bioavailable and 30 min following administration of a30 mg/kg dose, the plasma concentration is found to be 11.6 μM. TCN 238 does not affect the performance of the learned task. However, the expression level of GRM4 in the hippocampus is reliable down-regulated five days after treatment with TCN 238. In addition, the expression level of GABRA1, encoding GABAA α-subunit is downregulated five days after the treatment in the frontal cortex.

"125404-04-8" 相關(guān)產(chǎn)品信息
荥经县| 和硕县| 融水| 郸城县| 罗定市| 樟树市| 克什克腾旗| 自贡市| 桦南县| 永安市| 长泰县| 梅州市| 秦安县| 英山县| 罗田县| 怀柔区| 辉县市| 洞口县| 宜川县| 札达县| 麻城市| 台中市| 辽阳市| 绥滨县| 北碚区| 洛扎县| 松江区| 土默特右旗| 新宁县| 喀什市| 新化县| 山东省| 五寨县| 琼中| 桦川县| 喜德县| 炉霍县| 富阳市| 丰原市| 民县| 柳河县|